The introduction of nicotinamide as being a nicotine alternative in e-cigarette and smokeless merchandise signifies an important regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to act as a sedative at high dosages6. The claims made by